Bladder cancer is the seventh most common cancer in the UK, with just over 10,000 cases diagnosed each year. Around 5,000 people each year die from bladder cancer, making it the seventh most common cause of cancer death. The main risk factor for bladder cancer is increasing age. Additionally, smoking is also a key risk which is increased threefold in smokers.
With an aging population there is an increasing requirement to develop cost-effective and accurate means of diagnosing early stage bladder cancer.
allow the rapid detection of 1000s of metabolites and allows highly accurate descriptions of key chemical changes linked to such as cancer.
In this program, are using metabolomic approaches to define metabolite changes that can be used for the diagnosis of bladder cancer, stage and type.
Miss Tracy Knight
Miss Sarah Thomas